V002-3302 Screening compound: 3-(3-chlorophenyl)-1-(2-{4-[(4-fluorophenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-1-[2-(morpholin-4-yl)ethyl]urea

V002-3302 Screening compound: 3-(3-chlorophenyl)-1-(2-{4-[(4-fluorophenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-1-[2-(morpholin-4-yl)ethyl]urea
V002-3302 Screening compound: 3-(3-chlorophenyl)-1-(2-{4-[(4-fluorophenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-1-[2-(morpholin-4-yl)ethyl]urea alternative view

Chemical Structure Depiction of ChemDiv screening compound V002-3302
3-(3-chlorophenyl)-1-(2-{4-[(4-fluorophenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-1-[2-(morpholin-4-yl)ethyl]urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V002-3302

Molecular Formula

C29H32ClFN4O4S (C29 H32 ClFN4 O4 S)

Compound Name

3-(3-chlorophenyl)-1-(2-{4-[(4-fluorophenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-1-[2-(morpholin-4-yl)ethyl]urea

IUPAC name

3-(3-chlorophenyl)-1-(2-{4-[(4-fluorophenoxy)methyl]-4H5H6H7H-thieno[32-c]pyridin-5-yl}-2-oxoethyl)-1-[2-(morpholin-4-yl)ethyl]urea

SMILES

O=C(CN(CCN1CCOCC1)C(Nc1cccc(Cl)c1)=O)N(CC1)C(COc(cc2)ccc2F)c2c1scc2

InChI

InChI=1S/C29H32ClFN4O4S/c30-21-2-1-3-23(18-21)32-29(37)34(12-11-33-13-15-38-16-14-33)19-28(36)35-10-8-27-25(9-17-40-27)26(35)20-39-24-6-4-22(31)5-7-24/h1-7,9,17-18,26H,8,10-16,19-20H2,(H,32,37)/t26-/m0/s1

InChI Key

PZTLHOAJMSCRRZ-SANMLTNESA-N

MDL Number (MFCD)

MFCD19867735

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

587.11

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.691

Distribution Coefficient, logD

4.334

Water Solubility, LogSw

-4.80

Polar Surface Area

60.705

Acid Dissociation Constant (pKa)

12.16

Base Dissociation Constant (pKb)

7.50

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

37.90

V002-3302 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with V002-3302 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V002-3302?
Check Price and Availability of V002-3302, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V002-3302 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V002-3302
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V002-3302
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V002-3302 available by request